Clinical Trials Arena on MSN11h
Novartis reports Phase III efficacy and safety outcomes of SMA treatment
In this trial, the efficacy and safety of the therapy were evaluated against a sham control in treatment-naïve SMA Type 2 ...
pharmaphorum23h
Novartis bid to block generic Entresto in US suffers setback
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...
Novartis22h
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.